Cubist Systematic Strategies, LLC Avidity Biosciences, Inc. Transaction History

Cubist Systematic Strategies, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$6.3 - $11.35 $983,713 - $1.77 Million	156,145 New	156,145 $996,000
Q4 2022 Feb 14, 2023	BUY	$10.06 - $22.66 $1.19 Million - $2.67 Million	117,954 Added 1059.31%	129,089 $2.86 Million
Q3 2022 Nov 14, 2022	BUY	$15.46 - $23.43 $172,147 - $260,893	11,135 New	11,135 $182,000
Q1 2022 May 16, 2022	SELL	$14.2 - $23.78 $161,894 - $271,115	-11,401 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$20.4 - $28.66 $84,190 - $118,279	-4,127 Reduced 26.58%	11,401 $271,000
Q3 2021 Nov 15, 2021	BUY	$18.16 - $25.21 $281,988 - $391,460	15,528 New	15,528 $382,000
Q2 2021 Aug 16, 2021	SELL	$19.62 - $29.26 $263,202 - $392,522	-13,415 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$20.28 - $28.15 $272,056 - $377,632	13,415 New	13,415 $293,000

253

107M

224K

161K

Ticker RNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,127,000
Market Cap $1.51B
Description
Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat a range of serious diseases. The company's lead product candidate AOC 1001 is used for the treatment of myotonic dystrophy type 1, a rare monogenic...

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.